Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Johnson & Johnson (NYSE:JNJ) in the last three months. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Analysts have set 12-month price targets for Johnson & Johnson, revealing an average target of $190.31, a high estimate of $215.00, and a low estimate of $150.00. Observing a downward trend, the current average is 0.92…